These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 17977950)

  • 1. Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.
    Højlund K; Glintborg D; Andersen NR; Birk JB; Treebak JT; Frøsig C; Beck-Nielsen H; Wojtaszewski JF
    Diabetes; 2008 Feb; 57(2):357-66. PubMed ID: 17977950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment.
    Glintborg D; Højlund K; Andersen M; Henriksen JE; Beck-Nielsen H; Handberg A
    Diabetes Care; 2008 Feb; 31(2):328-34. PubMed ID: 18000176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired insulin activation and dephosphorylation of glycogen synthase in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.
    Glintborg D; Højlund K; Andersen NR; Hansen BF; Beck-Nielsen H; Wojtaszewski JF
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3618-26. PubMed ID: 18544618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
    Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
    Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome.
    Skov V; Glintborg D; Knudsen S; Jensen T; Kruse TA; Tan Q; Brusgaard K; Beck-Nielsen H; Højlund K
    Diabetes; 2007 Sep; 56(9):2349-55. PubMed ID: 17563058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of endurance exercise training on insulin signaling in human skeletal muscle: interactions at the level of phosphatidylinositol 3-kinase, Akt, and AS160.
    Frøsig C; Rose AJ; Treebak JT; Kiens B; Richter EA; Wojtaszewski JF
    Diabetes; 2007 Aug; 56(8):2093-102. PubMed ID: 17513702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome.
    Glintborg D; Frystyk J; Højlund K; Andersen KK; Henriksen JE; Hermann AP; Hagen C; Flyvbjerg A; Andersen M
    Clin Endocrinol (Oxf); 2008 Feb; 68(2):165-74. PubMed ID: 17803698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle.
    Kramer HF; Witczak CA; Fujii N; Jessen N; Taylor EB; Arnolds DE; Sakamoto K; Hirshman MF; Goodyear LJ
    Diabetes; 2006 Jul; 55(7):2067-76. PubMed ID: 16804077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome.
    Berria R; Gastaldelli A; Lucidi S; Belfort R; De Filippis E; Easton C; Brytzki R; Cusi K; Jovanovic L; DeFronzo R
    Clin Pharmacol Ther; 2006 Aug; 80(2):105-14. PubMed ID: 16890572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment.
    Glintborg D; Andersen M; Richelsen B; Bruun JM
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):652-8. PubMed ID: 19170716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Rab GTPase-activating protein AS160 integrates Akt, protein kinase C, and AMP-activated protein kinase signals regulating GLUT4 traffic.
    Thong FS; Bilan PJ; Klip A
    Diabetes; 2007 Feb; 56(2):414-23. PubMed ID: 17259386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intense electroacupuncture normalizes insulin sensitivity, increases muscle GLUT4 content, and improves lipid profile in a rat model of polycystic ovary syndrome.
    Johansson J; Feng Y; Shao R; Lönn M; Billig H; Stener-Victorin E
    Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E551-9. PubMed ID: 20663984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A
    Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astragalus polysaccharide improves insulin sensitivity in KKAy mice: regulation of PKB/GLUT4 signaling in skeletal muscle.
    Liu M; Wu K; Mao X; Wu Y; Ouyang J
    J Ethnopharmacol; 2010 Jan; 127(1):32-7. PubMed ID: 19800959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome.
    Glintborg D; Hermann AP; Andersen M; Hagen C; Beck-Nielsen H; Veldhuis JD; Henriksen JE
    Fertil Steril; 2006 Aug; 86(2):385-97. PubMed ID: 16782094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF; Nilas L; Madsbad S; Holst JJ
    Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calmodulin-binding domain of AS160 regulates contraction- but not insulin-stimulated glucose uptake in skeletal muscle.
    Kramer HF; Taylor EB; Witczak CA; Fujii N; Hirshman MF; Goodyear LJ
    Diabetes; 2007 Dec; 56(12):2854-62. PubMed ID: 17717281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
    Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
    Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose infusion causes insulin resistance in skeletal muscle of rats without changes in Akt and AS160 phosphorylation.
    Hoy AJ; Bruce CR; Cederberg A; Turner N; James DE; Cooney GJ; Kraegen EW
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1358-64. PubMed ID: 17785505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.